Ireland in the IRP Crossfire
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
$4995
Ireland's decision to exclude the UK from its international reference pricing (IRP) basket from 2027 will exert mild downward pressure on achievable ex-manufacturer prices for innovative medicines, a GlobalData analysis of POLI data across 22 recently reimbursed products finds.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
See what our customers are saying
Related reports
View more Product Type reports
New
New
New